Updated September 2026An unnamed moleculeAmble review
Three plan lengths, one flat rate at every dose, and a drug the product page never identifies.
The verdict
Amble charges $179 for one month of a once-weekly compounded GLP-1 injection, $160 a month on three and $135 on six, with the rate stated to hold at every dose. The page a buyer orders from never says which drug is in the vial.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- From $179/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Amble is a weight-loss telehealth program whose GLP-1 line is sold as a single product called compounded GLP-1 injections, described only as a once-per-week weight-loss injection. Anti-aging, medical kits and skin categories share the navigation, and a separate landing page offers a GLP-1 and GIP combination bundled with NAD+ at $250 for a one-month supply. That bundle page is the only place on the site where semaglutide and tirzepatide are named at all.
Who writes the prescription, and what do they see?
A licensed medical provider reviews the online medical intake and determines whether the medication is right for the patient, and secure messaging with scheduled check-ins runs afterwards at any hour. What the provider reads before writing is not described, and no clinician, medical group or medical director is named. Because the product carries no molecule, the choice between two drugs at very different market rates appears to be made somewhere inside that review rather than at checkout.
Every plan is stated to include supplies, shipping and ongoing clinical monitoring, with medication cold-shipped to the door and no pharmacy trip involved. A fast-acting anti-nausea medication is offered as an add-on to eligible patients rather than included, which is at least stated rather than left to be discovered later. There is no insurance requirement and no separate membership charge on any of the three plans.
What happens when the dose goes up?
Amble publishes a step-by-step dose-escalation schedule as one of the things a plan includes, and describes dose adjustments as available where clinically appropriate, which is more than a flat promise that nothing changes. The rate is stated to stay the same at every dose, so climbing does not cost more. What no page carries is a milligram, at any rung, for a molecule it has not named, so the escalation is described in the abstract and cannot be checked.
What the price includes
The plan table is three rows and reads cleanly: six months at $135, three at $160, one at $179. Nothing is struck through and no first-month rate is layered on top, which puts Amble ahead of several sellers charging similar figures. A promotional banner across the top of the site offers a GLP-1 at $150 with NAD+ at $100, on terms the banner itself does not explain.
What it claims, and what it cites
The product is compounded, and Amble's own disclosure states that compounded products are not approved or evaluated for safety, efficacy or quality by the FDA and that no efficacy claims are made for them. The compounding pharmacy is not named. The outcome statistics on the page come from a May 2025 survey of more than sixteen thousand members, using their own scale and tape-measure readings, and the disclosure notes that participants were compensated for taking part.
Where it holds up, and where it does not
- Strength: Three plan lengths priced with nothing struck through
- Strength: Rate stated to hold at every dose
- Strength: Supplies, shipping and monitoring included in every plan
- Strength: A dose-escalation schedule is named as part of the plan
- Strength: The survey behind the outcome figures is disclosed in full
- Limitation: The product page never names the molecule
- Limitation: No milligram appears anywhere on it
- Limitation: Anti-nausea support is an add-on rather than included
- Limitation: The compounding pharmacy and the clinicians are unnamed
- Limitation: The banner offer states no terms
What the evidence says about this kind of treatment
The assessment above is about Amble. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a six-month rate and will ask which drug it buys before ordering.
- Wrong for
- A reader comparing semaglutide against tirzepatide, since this page identifies neither.
How Amble compares
| Seller | Who it suits | Go |
|---|---|---|
 Eloria | Buyers who read the refill rate before the first-month rate | See Eloria → |
 Mondae | Buyers who want a low published compounded rate and few other details | See Mondae → |
 Nova MD | Buyers who will read which plan is already selected before they press start | See Nova MD → |
More GLP-1 telehealth sellers reviews: Bodi EnviBon HealthboostAGErxBrello HealthCalibrate HealthCandor Rx
Sponsored alternative
Bodybuilding Health+
A reader unwilling to prepay a year before seeing how the drug goes
Check Bodybuilding Health+ availability →Frequently asked
- Which GLP-1 does Amble prescribe?
- The product page does not say. Semaglutide and tirzepatide appear only on a separate bundle landing page, not on the plan a buyer orders.
- Does the price rise as the dose rises?
- No. Amble states the same price applies at every dose across all three plan lengths.
- Where do the weight-loss figures come from?
- A May 2025 survey of more than sixteen thousand members, using their own scale and tape readings, whose participants were compensated.
- Is Amble expensive compared with other GLP-1 telehealth sellers?
- Amble publishes a starting figure of $179/mo. Across the 252 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $178, which puts Amble above the median. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.